返回
Valeo Pharma Inc（VPHIF）價格
VPHIF 股價走勢圖
VPHIF 收益
Valeo Pharma Inc
$0
0%
$0
截至今日：Jan 20, 16:12:12 GMT-5
關鍵數據
前收市價
$0.0001
開盤價
$0.1181
當日範圍
$0.0001 - $0.1181
52週區間
$0.0001 - $0.1181
交易量
4.5K
平均成交量
147.1K
每股盈餘 (TTM)
-0.27
股息收益率
--
市值
$9.8K
什麼是 VPHIF？
Valeo Pharma, Inc. engages in the acquisition and in-licensing of branded pharmaceutical and hospital specialty products for sale. The company is headquartered in Kirkland, Quebec and currently employs 70 full-time employees. The firm acquires, or in-licenses branded pharmaceuticals and hospital specialty products for sale in Canada. The firm is engaged in the commercialization of prescription products in Canada with a focus on respiratory/allergy, ophthalmology and hospital specialty products. Its respiratory/allergy products include Enerzair Breezhaler, Atectura Breezhaler and Allerject. The ophthalmology products include Xiidra and Simbrinza. Its specialty products include Redesca, Onstryv, M-Eslon, Yondelis and Ametop Gel 4%. The firm's wholly owned subsidiary is VPI Pharmaceuticals Inc.